{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:45:07Z","timestamp":1775713507514,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CTQ2015-66313-R"],"award-info":[{"award-number":["CTQ2015-66313-R"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018-096100-B-I00"],"award-info":[{"award-number":["RTI2018-096100-B-I00"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12035-019-01813-4","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T05:09:55Z","timestamp":1578028195000},"page":"1938-1951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer\u2019s Disease Lymphoblast Alterations"],"prefix":"10.1007","volume":"57","author":[{"given":"Emilio","family":"Nu\u00f1ez-Borque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Gonz\u00e1lez-Naranjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Alqu\u00e9zar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Reinares-Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9948-2665","authenticated-orcid":false,"given":"Nuria E.","family":"Campillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-9440","authenticated-orcid":false,"given":"\u00c1ngeles","family":"Mart\u00edn-Requero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"issue":"5","key":"1813_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","volume":"6","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Grundke-Iqbal I (2010) Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement 6(5):420\u2013424. https:\/\/doi.org\/10.1016\/j.jalz.2010.04.006","journal-title":"Alzheimers Dement"},{"issue":"42","key":"1813_CR2","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","volume":"24","author":"K Herrup","year":"2004","unstructured":"Herrup K, Neve R, Ackerman SL, Copani A (2004) Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 24(42):9232\u20139239. https:\/\/doi.org\/10.1523\/JNEUROSCI.3347-04.2004","journal-title":"J Neurosci"},{"issue":"6","key":"1813_CR3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1017\/S1041610211002614","volume":"24","author":"C Cooper","year":"2012","unstructured":"Cooper C, Mukadam N, Katona C, Lyketsos CG, Ames D, Rabins P, Engedal K, de Mendonca Lima C et al (2012) Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr 24(6):856\u2013870. https:\/\/doi.org\/10.1017\/S1041610211002614","journal-title":"Int Psychogeriatr"},{"key":"1813_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejmech.2013.11.026","volume":"73","author":"P Gonzalez-Naranjo","year":"2014","unstructured":"Gonzalez-Naranjo P, Perez-Macias N, Campillo NE, Perez C, Aran VJ, Giron R, Sanchez-Robles E, Martin MI et al (2014) Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer\u2019s disease. Eur J Med Chem 73:56\u201372. https:\/\/doi.org\/10.1016\/j.ejmech.2013.11.026","journal-title":"Eur J Med Chem"},{"key":"1813_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejmech.2019.01.030","volume":"166","author":"P Gonzalez-Naranjo","year":"2019","unstructured":"Gonzalez-Naranjo P, Perez-Macias N, Perez C, Roca C, Vaca G, Giron R, Sanchez-Robles E, Martin-Fontelles MI et al (2019) Indazolylketones as new multitarget cannabinoid drugs. Eur J Med Chem 166:90\u2013107. https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.030","journal-title":"Eur J Med Chem"},{"issue":"3","key":"1813_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/1567205011310030002","volume":"10","author":"P Gonzalez-Naranjo","year":"2013","unstructured":"Gonzalez-Naranjo P, Campillo NE, Perez C, Paez JA (2013) Multitarget cannabinoids as novel strategy for Alzheimer disease. Curr Alzheimer Res 10(3):229\u2013239","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"1813_CR7","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87(5):1932\u20131936","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6441","key":"1813_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441):61\u201365. https:\/\/doi.org\/10.1038\/365061a0","journal-title":"Nature"},{"key":"1813_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1196\/annals.1369.052","volume":"1074","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z et al (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514\u2013536. https:\/\/doi.org\/10.1196\/annals.1369.052","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"1813_CR10","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1073\/pnas.1118167109","volume":"109","author":"FS den Boon","year":"2012","unstructured":"den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S, Kruse CG, Maccarrone M et al (2012) Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci U S A 109(9):3534\u20133539. https:\/\/doi.org\/10.1073\/pnas.1118167109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1813_CR11","doi-asserted-by":"publisher","unstructured":"Paez JA, Campillo NE (2018) Innovative therapeutic potential of cannabinoid receptors as targets in Alzheimer\u2019s disease and less well-known diseases. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867325666180226095132","DOI":"10.2174\/0929867325666180226095132"},{"issue":"8","key":"1813_CR12","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"BG Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25(8):1904\u20131913. https:\/\/doi.org\/10.1523\/JNEUROSCI.4540-04.2005","journal-title":"J Neurosci"},{"issue":"Pt 4","key":"1813_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/brain\/awr046","volume":"134","author":"J Mulder","year":"2011","unstructured":"Mulder J, Zilberter M, Pasquare SJ, Alpar A, Schulte G, Ferreira SG, Kofalvi A, Martin-Moreno AM et al (2011) Molecular reorganization of endocannabinoid signalling in Alzheimer\u2019s disease. Brain 134(Pt 4):1041\u20131060. https:\/\/doi.org\/10.1093\/brain\/awr046","journal-title":"Brain"},{"key":"1813_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.exger.2014.10.011","volume":"60","author":"AC Pascual","year":"2014","unstructured":"Pascual AC, Martin-Moreno AM, Giusto NM, de Ceballos ML, Pasquare SJ (2014) Normal aging in rats and pathological aging in human Alzheimer\u2019s disease decrease FAAH activity: modulation by cannabinoid agonists. Exp Gerontol 60:92\u201399. https:\/\/doi.org\/10.1016\/j.exger.2014.10.011","journal-title":"Exp Gerontol"},{"issue":"8","key":"1813_CR15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.neurobiolaging.2011.03.012","volume":"33","author":"KM Jung","year":"2012","unstructured":"Jung KM, Astarita G, Yasar S, Vasilevko V, Cribbs DH, Head E, Cotman CW, Piomelli D (2012) An amyloid beta42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer\u2019s disease. Neurobiol Aging 33(8):1522\u20131532. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.012","journal-title":"Neurobiol Aging"},{"key":"1813_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.redox.2016.12.029","volume":"11","author":"S Sun","year":"2017","unstructured":"Sun S, Hu F, Wu J, Zhang S (2017) Cannabidiol attenuates OGD\/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons. Redox Biol 11:577\u2013585. https:\/\/doi.org\/10.1016\/j.redox.2016.12.029","journal-title":"Redox Biol"},{"issue":"2","key":"1813_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1871524916666160504104624","volume":"17","author":"Q Zhuang","year":"2017","unstructured":"Zhuang Q, Dai C, Yang L, Wen H, Wang H, Jiang X, Zhang Y (2017) Stimulated CB1 cannabinoid receptor inducing ischemic tolerance and protecting neuron from cerebral ischemia. Cent Nerv Syst Agents Med Chem 17(2):141\u2013150. https:\/\/doi.org\/10.2174\/1871524916666160504104624","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"5","key":"1813_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/138955709788167628","volume":"9","author":"NE Campillo","year":"2009","unstructured":"Campillo NE, Paez JA (2009) Cannabinoid system in neurodegeneration: new perspectives in Alzheimer\u2019s disease. Mini-Rev Med Chem 9(5):539\u2013559","journal-title":"Mini-Rev Med Chem"},{"key":"1813_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-9-8","volume":"9","author":"AM Martin-Moreno","year":"2012","unstructured":"Martin-Moreno AM, Brera B, Spuch C, Carro E, Garcia-Garcia L, Delgado M, Pozo MA, Innamorato NG et al (2012) Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation 9:8. https:\/\/doi.org\/10.1186\/1742-2094-9-8","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1813_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","volume":"79","author":"AM Martin-Moreno","year":"2011","unstructured":"Martin-Moreno AM, Reigada D, Ramirez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML (2011) Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease. Mol Pharmacol 79(6):964\u2013973. https:\/\/doi.org\/10.1124\/mol.111.071290","journal-title":"Mol Pharmacol"},{"issue":"6","key":"1813_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ana.10208","volume":"51","author":"RM Holsinger","year":"2002","unstructured":"Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer\u2019s disease. Ann Neurol 51(6):783\u2013786. https:\/\/doi.org\/10.1002\/ana.10208","journal-title":"Ann Neurol"},{"issue":"1","key":"1813_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"LB Yang","year":"2003","unstructured":"Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L et al (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9(1):3\u20134. https:\/\/doi.org\/10.1038\/nm0103-3","journal-title":"Nat Med"},{"issue":"52","key":"1813_CR23","doi-asserted-by":"publisher","first-page":"19198","DOI":"10.1073\/pnas.0505203102","volume":"102","author":"X Yue","year":"2005","unstructured":"Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z et al (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer\u2019s disease animal model. Proc Natl Acad Sci U S A 102(52):19198\u201319203. https:\/\/doi.org\/10.1073\/pnas.0505203102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1813_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.neurobiolaging.2004.10.005","volume":"26","author":"O Zohar","year":"2005","unstructured":"Zohar O, Pick CG, Cavallaro S, Chapman J, Katzav A, Milman A, Alkon DL (2005) Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Neurobiol Aging 26(8):1167\u20131175. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.10.005","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1813_CR25","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","volume":"13","author":"G Mushtaq","year":"2014","unstructured":"Mushtaq G, Greig NH, Khan JA, Kamal MA (2014) Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets 13(8):1432\u20131439","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"1813_CR26","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1046\/j.1471-4159.2000.751320.x","volume":"75","author":"B Li","year":"2000","unstructured":"Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P, Brimijoin S, Hinrichs SH et al (2000) Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75(3):1320\u20131331","journal-title":"J Neurochem"},{"issue":"5","key":"1813_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.410360506","volume":"36","author":"MM Mesulam","year":"1994","unstructured":"Mesulam MM, Geula C (1994) Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 36(5):722\u2013727. https:\/\/doi.org\/10.1002\/ana.410360506","journal-title":"Ann Neurol"},{"issue":"4","key":"1813_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","volume":"110","author":"MM Mesulam","year":"2002","unstructured":"Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110(4):627\u2013639","journal-title":"Neuroscience"},{"issue":"2","key":"1813_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrn1035","volume":"4","author":"S Darvesh","year":"2003","unstructured":"Darvesh S, Hopkins DA, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 4(2):131\u2013138. https:\/\/doi.org\/10.1038\/nrn1035","journal-title":"Nat Rev Neurosci"},{"key":"1813_CR30","doi-asserted-by":"publisher","unstructured":"Lian W, Fang J, Xu L, Zhou W, Kang XW, Jia H, Liu AL, Du GH (2017) DL0410 ameliorates memory and cognitive impairments induced by scopolamine via increasing cholinergic neurotransmission in mice. Molecules 22(3). https:\/\/doi.org\/10.3390\/molecules22030410","DOI":"10.3390\/molecules22030410"},{"issue":"1","key":"1813_CR31","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41598-017-02114-3","volume":"7","author":"I Ponzoni","year":"2017","unstructured":"Ponzoni I, Sebastian-Perez V, Requena-Triguero C, Roca C, Martinez MJ, Cravero F, Diaz MF, Paez JA et al (2017) Hybridizing feature selection and feature learning approaches in QSAR modeling for drug discovery. Sci Rep 7(1):2403. https:\/\/doi.org\/10.1038\/s41598-017-02114-3","journal-title":"Sci Rep"},{"key":"1813_CR32","doi-asserted-by":"publisher","unstructured":"Pruszak J, Just L, Isacson O, Nikkhah G (2009) Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains. Curr Protoc Stem Cell Biol Chapter 2:Unit 2D 5. doi:https:\/\/doi.org\/10.1002\/9780470151808.sc02d05s11","DOI":"10.1002\/9780470151808.sc02d05s11"},{"key":"1813_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2202-13-120","volume":"13","author":"LH Yin","year":"2012","unstructured":"Yin LH, Shen H, Diaz-Ruiz O, Backman CM, Bae E, Yu SJ, Wang Y (2012) Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson\u2019s disease. BMC Neurosci 13:120. https:\/\/doi.org\/10.1186\/1471-2202-13-120","journal-title":"BMC Neurosci"},{"issue":"2","key":"1813_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","volume":"89","author":"F Denizot","year":"1986","unstructured":"Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89(2):271\u2013277","journal-title":"J Immunol Methods"},{"issue":"4","key":"1813_CR35","first-page":"220","volume":"11","author":"D Ibarreta","year":"1997","unstructured":"Ibarreta D, Parrilla R, Ayuso MS (1997) Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 11(4):220\u2013227","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"1813_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neurobiolaging.2013.09.021","volume":"35","author":"C Alquezar","year":"2014","unstructured":"Alquezar C, Esteras N, de la Encarnacion A, Alzualde A, Moreno F, Lopez de Munain A, Martin-Requero A (2014) PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers. Neurobiol Aging 35(4):886\u2013898. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.021","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1813_CR37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12035-014-8870-y","volume":"52","author":"N Esteras","year":"2015","unstructured":"Esteras N, Alquezar C, Bartolome F, de la Encarnacion A, Bermejo-Pareja F, Molina JA, Martin-Requero A (2015) G1\/S cell cycle checkpoint dysfunction in lymphoblasts from sporadic Parkinson\u2019s disease patients. Mol Neurobiol 52(1):386\u2013398. https:\/\/doi.org\/10.1007\/s12035-014-8870-y","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1813_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40263-018-0515-7","volume":"32","author":"P Del Cerro","year":"2018","unstructured":"Del Cerro P, Alquezar C, Bartolome F, Gonzalez-Naranjo P, Perez C, Carro E, Paez JA, Campillo NE et al (2018) Activation of the cannabinoid type 2 receptor by a novel indazole derivative normalizes the survival pattern of lymphoblasts from patients with late-onset Alzheimer\u2019s disease. CNS Drugs 32(6):579\u2013591. https:\/\/doi.org\/10.1007\/s40263-018-0515-7","journal-title":"CNS Drugs"},{"issue":"4","key":"1813_CR39","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2012.10.014","volume":"34","author":"N Esteras","year":"2013","unstructured":"Esteras N, Alquezar C, Bermejo-Pareja F, Bialopiotrowicz E, Wojda U, Martin-Requero A (2013) Downregulation of extracellular signal-regulated kinase 1\/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer\u2019s disease patients. Neurobiol Aging 34(4):1090\u20131100. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.10.014","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1813_CR40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00018-007-7081-3","volume":"64","author":"F Bartolome","year":"2007","unstructured":"Bartolome F, de Las CN, Munoz U, Bermejo F, Martin-Requero A (2007) Impaired apoptosis in lymphoblasts from Alzheimer's disease patients: cross-talk of Ca2+\/calmodulin and ERK1\/2 signaling pathways. Cell Mol Life Sci 64(11):1437\u20131448. https:\/\/doi.org\/10.1007\/s00018-007-7081-3","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"1813_CR41","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.neurobiolaging.2007.03.013","volume":"29","author":"U Munoz","year":"2008","unstructured":"Munoz U, Bartolome F, Bermejo F, Martin-Requero A (2008) Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer\u2019s dementia patients. Neurobiol Aging 29(10):1474\u20131484. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.03.013","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1813_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/cc.5.1.2270","volume":"5","author":"N Agell","year":"2006","unstructured":"Agell N, Jaumot M, Rodriguez-Vilarrupla A, Brun S, Abella N, Canela N, Estanyol JM, Bachs O (2006) The diverging roles of calmodulin and PKC in the regulation of p21 intracellular localization. Cell Cycle 5(1):3\u20136. https:\/\/doi.org\/10.4161\/cc.5.1.2270","journal-title":"Cell Cycle"},{"issue":"2","key":"1813_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0962-8924(02)00043-0","volume":"13","author":"O Coqueret","year":"2003","unstructured":"Coqueret O (2003) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13(2):65\u201370","journal-title":"Trends Cell Biol"},{"key":"1813_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fphar.2014.00037","volume":"5","author":"E Aso","year":"2014","unstructured":"Aso E, Ferrer I (2014) Cannabinoids for treatment of Alzheimer\u2019s disease: moving toward the clinic. Front Pharmacol 5:37. https:\/\/doi.org\/10.3389\/fphar.2014.00037","journal-title":"Front Pharmacol"},{"issue":"6","key":"1813_CR45","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nm.4311","volume":"23","author":"A Bilkei-Gorzo","year":"2017","unstructured":"Bilkei-Gorzo A, Albayram O, Draffehn A, Michel K, Piyanova A, Oppenheimer H, Dvir-Ginzberg M, Racz I et al (2017) A chronic low dose of delta(9)-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med 23(6):782\u2013787. https:\/\/doi.org\/10.1038\/nm.4311","journal-title":"Nat Med"},{"issue":"3","key":"1813_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0014-2999(03)01856-9","volume":"471","author":"JL Wiley","year":"2003","unstructured":"Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471(3):185\u2013193","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1813_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pbb.2006.08.006","volume":"85","author":"TU Jarbe","year":"2006","unstructured":"Jarbe TU, Ross T, DiPatrizio NV, Pandarinathan L, Makriyannis A (2006) Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats. Pharmacol Biochem Behav 85(1):243\u2013252. https:\/\/doi.org\/10.1016\/j.pbb.2006.08.006","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"1813_CR48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/hipo.10081","volume":"13","author":"RE Hampson","year":"2003","unstructured":"Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA (2003) Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus 13(5):543\u2013556. https:\/\/doi.org\/10.1002\/hipo.10081","journal-title":"Hippocampus"},{"issue":"5","key":"1813_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuint.2004.11.005","volume":"46","author":"D Van Dam","year":"2005","unstructured":"Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP (2005) Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochem Int 46(5):409\u2013422. https:\/\/doi.org\/10.1016\/j.neuint.2004.11.005","journal-title":"Neurochem Int"},{"issue":"5","key":"1813_CR50","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1021\/jacs.8b11414","volume":"141","author":"X Wang","year":"2019","unstructured":"Wang X, Li P, Ding Q, Wu C, Zhang W, Tang B (2019) Observation of acetylcholinesterase in stress-induced depression phenotypes by two-photon fluorescence imaging in the mouse brain. J Am Chem Soc 141(5):2061\u20132068. https:\/\/doi.org\/10.1021\/jacs.8b11414","journal-title":"J Am Chem Soc"},{"issue":"3","key":"1813_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0014-2999(99)00643-3","volume":"383","author":"C Bejar","year":"1999","unstructured":"Bejar C, Wang RH, Weinstock M (1999) Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 383(3):231\u2013240","journal-title":"Eur J Pharmacol"},{"key":"1813_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-015-0033-8","volume":"10","author":"U Neumann","year":"2015","unstructured":"Neumann U, Rueeger H, Machauer R, Veenstra SJ, Lueoend RM, Tintelnot-Blomley M, Laue G, Beltz K et al (2015) A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-beta and neuroinflammation in APP transgenic mice. Mol Neurodegener 10:44. https:\/\/doi.org\/10.1186\/s13024-015-0033-8","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1813_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12035-012-8262-0","volume":"46","author":"T Arendt","year":"2012","unstructured":"Arendt T (2012) Cell cycle activation and aneuploid neurons in Alzheimer\u2019s disease. Mol Neurobiol 46(1):125\u2013135. https:\/\/doi.org\/10.1007\/s12035-012-8262-0","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1813_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1535-6108(03)00308-8","volume":"4","author":"RH Weiss","year":"2003","unstructured":"Weiss RH (2003) p21Waf1\/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4(6):425\u2013429","journal-title":"Cancer Cell"},{"issue":"15","key":"1813_CR55","first-page":"5784","volume":"61","author":"C Sanchez","year":"2001","unstructured":"Sanchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW et al (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61(15):5784\u20135789","journal-title":"Cancer Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01813-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T01:06:22Z","timestamp":1609549582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01813-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01813-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"31 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study protocols were approved by the Hospital Doce de Octubre and the Spanish Council of Higher Research Institutional Review Board and are in accordance with National and European Union Guidelines. In all cases, peripheral blood samples were taken after written informed consent of the patients or their relatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}